Landiolol was administered at target concentrations of 0.5 and 1.0 mcg/mL for each 30 min at each target concentration.

2 trials

Sponsors

Department of Anesthesiology and CCM, Asahikawa Medical University

Conditions

Cardiac diseasePeripheral arterial disease

Unknown Phase

Pharmakocinetics of landiolol in patients with peripheral arterial disease

Active, not recruitingJPRN-UMIN000015077

Department of Anesthesiology and CCM, Asahikawa Medical UniversityPeripheral arterial disease

Start: 2007-11-01Target: 8Updated: 2026-06-29

Pharmakocinetics of landiolol in patients undergoing cardiac surgery

Active, not recruitingJPRN-UMIN000023699

Department of Anesthesiology and CCM, Asahikawa Medical UniversityCardiac disease

Start: 2016-08-26Target: 15Updated: 2026-06-29